FindTrial
Sign In

TO see THE efficiency OF PARAVERTEBRAL BLOCK AND INTERCOSTAL NERVE BLOCK FOR HERPES ZOSTER

TO ASSESS THE EFFICACY OF PARAVERTEBRAL BLOCK AND INTERCOSTAL NERVE BLOCK FOR THORACIC HERPES ZOSTER : RANDOMIZED COMPARATIVE STUDY - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101352
Enrollment
40
Registered
2026-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B029- Zoster without complications

Interventions

Intervention1: paravertebral block: 15 ml of 0.25% Bupivacaine with 8 mg of Dexamethasone Intervention2: intercostal block: 2.5 mL bupivacaine HCl 0.25% + 2 mg dexamethasone is injected for each leve

Sponsors

NIDHI CHINCHOLI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age greater 40 years of age of either gender Herpes zoster greater 1 week since onset of rash HZ involving up to 2 thoracic dermatomes Numerical rating score (NRS)greater 4 Pain refractory to conservative management

Exclusion criteria

Exclusion criteria: Infection at site of injection Patients with coagulopathy or on anticoagulants Patients on chemotherapy or immunosuppressive drugs Any contraindication to neuraxial injection Uncontrolled medical illness Hypersensitivity to LA Pregnancy and lactating women

Design outcomes

Primary

MeasureTime frame
decrease in NRS score post block for herpes zosterTimepoint: decrease in pain NRS score post block for thoracic herpes zoster—

Secondary

MeasureTime frame
decrease in incidence of PHNTimepoint: 6 months—

Countries

India

Contacts

Public ContactNidhi Chincholi

JSS MEDICAL COLLEGE , Mysore

prathibarmatche@jssuni.edu.in9108930742

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026